| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other (expense) income, net | -569 | -1,691 | 75 | 3,525 |
| Net loss | -25,117 | -53,235 | -76,088 | -62,141 |
| Net loss per share, basic (in dollars per share) | -0.28 | -0.63 | -0.92 | -0.75 |
| Net loss per share, diluted (in dollars per share) | -0.28 | -0.63 | -0.92 | -0.75 |
| Weighted-average common shares outstanding, basic (in shares) | 90,090,397 | 84,412,200 | 83,055,066 | 82,485,199 |
| Weighted-average common shares outstanding, diluted (in shares) | 90,090,397 | 84,412,200 | 83,055,066 | 82,485,199 |
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)